Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ULTRACUR-PRO is a high-bioavailability curcumin formulation developed by Nupathways, utilizing a proprietary protein-bound curcumin complex to overcome the poor gastrointestinal absorption typical of standard turmeric extracts. The active curcuminoids function as multi-target anti-inflammatory agents by inhibiting the activation of nuclear factor-kappa B (NF-κB) and reducing the expression of pro-inflammatory enzymes such as cyclooxygenase-2 (COX-2) and various cytokines, including TNF-α and IL-6. Primarily marketed as a professional-grade nutraceutical for joint health and systemic inflammation, ULTRACUR-PRO is designed for clinical applications where high systemic concentrations of curcumin are required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ULTRACUR-PRO.